Neohormone systems as exciting targets for drug development
- 31 May 2006
- journal article
- other
- Published by Elsevier in Trends in Endocrinology & Metabolism
- Vol. 17 (4) , 123
- https://doi.org/10.1016/j.tem.2006.03.004
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Relaxin: Antifibrotic Properties and Effects in Models of DiseaseClinical Medicine & Research, 2005
- Novel drug development opportunity for relaxin in acute myocardial infarction: evidences from a swine modelThe FASEB Journal, 2005
- Evolution of the relaxin-like peptide familyBMC Ecology and Evolution, 2005
- Relaxin: new peptides, receptors and novel actionsTrends in Endocrinology & Metabolism, 2003
- Relaxin peptides are new global playersTrends in Endocrinology & Metabolism, 2002
- Relaxin induces vascular endothelial growth factor expression and angiogenesis selectively at wound sitesWound Repair and Regeneration, 2000